Paclitaxel-eluting stents show superiority to balloon angioplasty and bare metal stents in femoropopliteal disease: twelve-month Zilver PTX randomized study results.
about
Angioplasty versus stenting for iliac artery lesionsAtherectomy for peripheral arterial diseaseNew developments in the clinical use of drug-coated balloon catheters in peripheral arterial diseaseSupera self-expanding stents for endovascular treatment of femoropopliteal disease: a review of the clinical evidencePaclitaxel Drug-Eluting Stents in Peripheral Arterial Disease: A Health Technology AssessmentFeasibility study for removing calcified material using a planar rectangular ultrasound transducerRemoving atherosclerotic plaque created using high cholesterol diet in rabbit using ultrasoundCritical limb ischemia: current approach and future directions.Self-expanding stents and aortoiliac occlusive disease: a review of the literature.Critical evaluation of stents in the peripheral arterial disease of the superficial femoral artery - focus on the paclitaxel eluting stentLow-Dose Paclitaxel-Coated Versus Uncoated Percutaneous Transluminal Balloon Angioplasty for Femoropopliteal Peripheral Artery Disease: One-Year Results of the ILLUMENATE European Randomized Clinical Trial (Randomized Trial of a Novel Paclitaxel-CoaProlonged high-pressure balloon angioplasty of femoropopliteal lesions: Impact on stent implantation rate and mid-term outcomeDelayed inhaled carbon monoxide mediates the regression of established neointimal lesionsPeripheral arterial disease: a literature review.Bare metal stent versus paclitaxel eluting stent for intermediate length femoropopliteal arterial lesions (BATTLE trial): study protocol for a randomized controlled trial.Treating femoropopliteal disease: established and emerging technologiesEffects of recombinant human type I pancreatic elastase on human atherosclerotic arteriesDrug-coated balloon versus standard percutaneous transluminal angioplasty for the treatment of superficial femoral and popliteal peripheral artery disease: 12-month results from the IN.PACT SFA randomized trial.Lower limb peripheral arterial disease (clinical guideline 147): a guideline summary.Antiplatelet therapy for peripheral arterial disease and critical limb ischemia: guidelines abound, but where are the data?Laser Atherectomy for Treatment of Femoropopliteal In-Stent Restenosis.Commentary: Excimer Laser in Treating Femoropopliteal In-Stent Restenosis: Can Early Success Be Maintained Over Long-term Follow-up?Point-of-care seeding of nitinol stents with blood-derived endothelial cells.Early results with LifeStent implantation in RESILIENT and non-RESILIENT inclusion criteria patients.Outcomes for clinical studies assessing drug and revascularization therapies for claudication and critical limb ischemia in peripheral artery diseaseCost-effectiveness of medical, endovascular and surgical management of peripheral vascular disease.Femoropopliteal Artery Stent Thrombosis: Report From the Excellence in Peripheral Artery Disease Registry.A budget impact model for paclitaxel-eluting stent in femoropopliteal disease in FranceDurable Clinical Effectiveness With Paclitaxel-Eluting Stents in the Femoropopliteal Artery: 5-Year Results of the Zilver PTX Randomized TrialManagement of Critical Limb Ischemia.Economic analysis of endovascular drug-eluting treatments for femoropopliteal artery disease in the UK.Clinical impact and risk stratification of balloon angioplasty for femoropopliteal disease in nitinol stenting era: Retrospective multicenter study using propensity score matching analysisA single stent strategy in patients with lifestyle limiting claudication: 3-year results from the Durability II trial.Angiographic characteristics of femoropopliteal in-stent restenosis: association with long-term outcomes after endovascular intervention.Adventitial nab-rapamycin injection reduces porcine femoral artery luminal stenosis induced by balloon angioplasty via inhibition of medial proliferation and adventitial inflammation.Cost-effectiveness of superficial femoral artery endovascular interventions in the UK and Germany: a modelling study.Inhibitory effect of sustained perivascular delivery of paclitaxel on neointimal hyperplasia in the jugular vein after open cutdown central venous catheter placement in rats.Drug-coated balloons for coronary and peripheral interventional procedures.Peripheral applications of drug-coated balloons: past, present and future.Drug-coated balloons and their place in treating peripheral arterial disease.
P2860
Q24187772-BFD15004-944A-42EB-A841-5163CF53DC8FQ24197925-80F5F7A5-16D7-4EC2-B5D1-09200E20D832Q26740218-EA2CADCE-570B-48FB-A1BE-A26A1D917590Q26800276-C9C6C0C8-2DD6-4210-89CF-C9DCA8970FA9Q28070571-2176E345-87F9-4115-8E7A-90D0ABB717B4Q30355293-A3F02B83-3ECC-41BB-A517-36F595CBB3ADQ30419463-874F8417-A6D2-426A-A161-B120CADFADADQ30458139-4F1DDA59-78C3-4EBB-9D1E-0466193F0FE7Q33583475-5A9E015F-BA31-460D-8577-94B803A28D3BQ33710114-3C7771B3-6F0C-4205-903E-F9A170B4F6CAQ33765190-6BCE7DCD-091E-4518-83C4-2D82634AAF14Q33826534-14C8DDEE-82DA-4C23-B40B-E0FBE1B6B408Q33882962-B5378E74-B6C8-4103-86FE-D73DDC91AAE7Q34451668-FF33266E-7559-42E5-B139-1E034C749784Q34484871-0FF7F048-AAEC-4C9A-8DE3-1AD915420B84Q34513862-62E6A26A-41C9-46D3-BE80-08C180C6B0E8Q34743883-180903EF-06EC-4EAD-B4B0-AE4589D0F373Q35069850-41FFACF3-738E-4170-B9C2-B3E8DE1BCE82Q35077945-3FCD2810-AB91-4B36-ADFA-F3AD8329626EQ35216396-EEEAC92D-FBA9-4768-B84C-BE9961D77C52Q35679312-670DBCDE-1BC3-4476-9C97-9C656A1A6FFFQ35696046-E2B12379-6FA6-4B00-9F41-2DC3E7A69BC7Q35764630-F2366F6B-5E0F-48D9-9B72-5E19E5316175Q35765692-B268100D-6D95-4CC3-B432-4EF9324F3943Q35866198-97DD3B76-94F7-474A-A223-0EC4C4F3FC9FQ36296649-5BBF3D09-BC6E-4AFE-8C1E-BD32BA8513F0Q36550874-247AC7CB-50CC-4B32-810B-8830BC07EAF7Q36678307-FFDBEE84-477C-4E17-8948-286B460D8E35Q36774583-089401F7-1DDE-4360-87EC-52DE4F1A640DQ36786241-FB79C56A-A84E-4383-B8FD-A16795E37AD5Q36920052-D1D887E3-4202-42EC-98DE-14446CA22876Q37129580-A5409226-8B5D-4563-8081-296A4BD4BCDBQ37257331-A80714BA-276D-4112-B7F0-853EA4998326Q37333232-06CED1BE-CB80-4DBD-BBFC-04EDAE94CFFFQ37463102-2345E13C-9096-4027-A64F-CB1AC6EDDDF8Q37598199-6A100911-B9E2-492C-98F5-D2E4C4262036Q37641989-B40C965F-01F9-4535-ACA2-C32B843BFB1BQ38028877-61DEC521-2A84-48C9-B34C-3E11A93ABD29Q38036967-141BCB93-39AD-4C51-ADB5-DA2203CCCD4BQ38070705-FA74FAED-81F9-423D-A33F-15A47F39598D
P2860
Paclitaxel-eluting stents show superiority to balloon angioplasty and bare metal stents in femoropopliteal disease: twelve-month Zilver PTX randomized study results.
description
2011 nî lūn-bûn
@nan
2011 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
name
Paclitaxel-eluting stents show ...... PTX randomized study results.
@ast
Paclitaxel-eluting stents show ...... PTX randomized study results.
@en
Paclitaxel-eluting stents show ...... PTX randomized study results.
@nl
type
label
Paclitaxel-eluting stents show ...... PTX randomized study results.
@ast
Paclitaxel-eluting stents show ...... PTX randomized study results.
@en
Paclitaxel-eluting stents show ...... PTX randomized study results.
@nl
prefLabel
Paclitaxel-eluting stents show ...... PTX randomized study results.
@ast
Paclitaxel-eluting stents show ...... PTX randomized study results.
@en
Paclitaxel-eluting stents show ...... PTX randomized study results.
@nl
P2093
P1476
Paclitaxel-eluting stents show ...... PTX randomized study results.
@en
P2093
Anthony O Ragheb
Gary M Ansel
H Bob Smouse
J King White
Lindsay S Machan
Mark W Burket
Michael D Dake
Michael R Jaff
Richard R Saxon
Scott A Snyder
P304
P356
10.1161/CIRCINTERVENTIONS.111.962324
P577
2011-09-27T00:00:00Z